医学
恶性肿瘤
放射科
磁共振成像
肝细胞癌
结核(地质)
超声波
医学物理学
内科学
古生物学
生物
作者
Eleonora Terzi,Carmen Ayuso,Fabio Piscaglia,Jordi Bruix
出处
期刊:Seminars in Liver Disease
[Georg Thieme Verlag KG]
日期:2021-07-23
卷期号:42 (01): 104-111
被引量:6
标识
DOI:10.1055/s-0041-1732356
摘要
Abstract The American College of Radiology has released the Liver Imaging Reporting and Data System (LI-RADS) scheme which categorizes focal liver lesions (FLLs) in patients at risk for hepatocellular carcinoma (HCC) according to the degree of risk of nodules to be HCC. It subgroups FLL in LR-1 (definitely benign), LR-2 (probably benign), LR-3 (intermediate probability of malignancy), LR-4 (probably HCC), LR-5 (definitely HCC), and LR-M (probable malignancy not specific for HCC). Computed tomography/magnetic resonance imaging (CT/MRI) and contrast enhanced ultrasound (CEUS) LI-RADS diagnostic algorithm have the goal to standardize the acquisition, interpretation, reporting, and data collection for imaging examinations in patients at risk for HCC. Nevertheless, there remain controversial issues that should be dealt with. The aim of this review is to discuss the pros and cons of the interpretation and reporting part of CT/MRI and CEUS LI-RADS diagnostic algorithm to permit future refinements of the scheme and optimize patient and nodule management.
科研通智能强力驱动
Strongly Powered by AbleSci AI